Aifred Health

The Aifred Health team is very excited to share that we’ve been awarded our second U.S. patent! This is another milestone for the team and a testament to the deep innovation behind our platform. Grateful to everyone who helped make this happen! Patent No: US 12,400,763 B2

The Aifred Health team is thrilled to share the publication of the results of our North American clinical trial which demonstrate the effectiveness of our novel AI-driven platform in major depression. The publication can be accessed at: lnkd.in/ebFv8Smf #AIinmentalhealth

The Aifred team is thrilled to unveil our latest paper in NPJ Mental Health Research, showcasing the rigorous development and validation of our AI model for personalized treatment response prediction in major depression. Access the article here: rdcu.be/es08I

Quel parcours ! D'une start-up montréalaise à un gagnant du XPRIZE AI for Good, jusqu'à l'approbation de Santé Canada ! lnkd.in/eN52vKcQ

What a journey! From a Montreal start-up, to an #XPRIZE AI for Good Winner, to Health Canada Approval! We are now looking for a Canadian commercialization partner and we invite you to contact us if you have an interest in learning more! lnkd.in/ezcjx6JN

Nous sommes impatients de commencer à travailler sur nos dossiers réglementaires, une étape cruciale pour mettre notre technologie à la disposition des cliniciens et des patients aux États-Unis et au Canada.

Bien que les résultats définitifs soient encore en attente du traitement complet des données, l'analyse préliminaire de l'échantillon d'analyse complet suggère que la plateforme a été encore plus performante que nous l'avions espéré !

Nous sommes ravis d'annoncer la conclusion de notre essai clinique nord-américain et le lancement des dépôts réglementaires pour notre plateforme d'aide à la décision clinique basée sur l'IA afin de personnaliser le choix du traitement dans le cas de la dépression majeure.

We are eager to now start working on our regulatory filings as a critical next step in making our technology available to clinicians and patients across the US and Canada.

While final results are still pending full processing of the data, preliminary analysis of the complete analysis sample suggests the platform has performed even better than we’d hoped!

We are incredibly excited to announce the conclusion of its North American trial and initiation of regulatory approval processes in the US and Canada for our AI-driven clinical decision support platform to personalize and optimize treatment choice in major depression.

We are proud to announce the extension of our research relationship with the US Government and US Dept. of Veterans Affairs with the addition of 4 new clinical trial sites: VA Cincinnati VA Gainesville VA Philadelphia VA Phoenix We are honored to be working closely with the #VA.

The Aifred Health team had a fantastic evening celebrating many accomplishments, including our #MDSAP certification! The #MDSAP certification confirms our ongoing commitment to maintaining the highest quality standards for AI-enabled software as medical device in mental health.

Today, Aifred Health turns 6 years old! We are proud to stand together as a team, year after year, continuing to forge ahead with a shared passion for Aifred’s mission to significantly improve patient outcomes in the field of mental health. #aifredhealth #mentalhealth #AI

Aifred Health est fier d'annoncer qu'il a déposé son premier brevet ! Pour plus d'informations, veuillez consulter notre communiqué de presse: lnkd.in/eNA2aiSS #aiinhealthcare #ai #IP #patent #innovation #aifredhealth #clinicaldecisionsupport #mentalhealth

Aifred Health is proud to announce it has been granted its first patent! For more information, please see our press release: lnkd.in/eU36QKYg #aiinhealthcare #ai #IP #patent #innovation #aifredhealth #clinicaldecisionsupport #mentalhealth

The #AifredHealth team was very happy to get together recently to celebrate a big milestone: Aifred’s 5th birthday! Join us in celebrating this company milestone! #AI #mentalhealth #digitalhealth #innovation

Aifred is pleased to welcome Dr. Sandra Stratford to its Board of Directors. A former Fortune 100 Chief Medical Officer, spearheading innovative employee health and well-being initiatives, she also currently serves on the Board of Trustees for the Dana-Farber Cancer Institute.